Ephylone (N-ethylpentylone, bk-ethyl-K), also known as 5-EAPB analog or β-keto-ethyl-K, is a synthetic cathinone of the MDxx class combining entactogenic and stimulant properties. It is the N-ethyl analog of pentylone (bk-MBDP) and a structural member of the N-alkyl-methylenedioxypentiophenone family, placing it in the same chemical neighborhood as ethylone, methylone, and butylone.
Ephylone's pharmacological profile combines serotonin, dopamine, and norepinephrine activity consistent with other MDxx cathinones, producing experiences that blend entactogenic qualities (emotional openness, sociability enhancement) with stimulant effects (energy, focus, euphoria). Like other cathinones with methylenedioxy substitution, ephylone shares a structural motif with MDMA and produces a qualitatively similar but pharmacologically distinct experience — the empathogenic warmth is typically described as milder than MDMA, with more prominent stimulant character.
The duration of ephylone is relevant to its harm profile: like other cathinones, it tends toward shorter duration than the corresponding non-beta-ketone phenethylamines, with primary effects lasting 2–4 hours. This shorter duration contributes to the redosing cycle characteristic of cathinone use. Community accounts of ephylone functional use emphasize its utility for productivity and social enhancement at controlled doses, with a harm reduction emphasis on avoiding frequency escalation.
Ephylone is substantially understudied, emerging in drug early warning systems in multiple jurisdictions in the 2010s. As with other under-characterized NPS cathinones, extrapolation from structurally related and better-characterized compounds provides the principal basis for harm assessment. All MDxx cathinone harm reduction guidance — including the strict avoidance of MAOI combinations and the precautionary spacing of use — applies to ephylone.
Safety at a Glance
High Risk- Test Your Substance
- MDxx cathinones cannot be reliably distinguished by appearance. Use reagent testing:
- Toxicity: Entactogen and Stimulant Risk Profile Ephylone combines the risk profiles of both classes: Stimulant risks: - Cardiov...
- Dangerous with: 25x-NBOH, 25x-NBOMe, Atropa belladonna, Datura, MDMA (+3 more)
- Overdose risk: overdose deaths indicate that ephylone is extremely toxic at very high dosages. The DEA claimed a...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
oral
Duration
oral
Total: 4 hrs – 8 hrsHow It Feels
The onset of ephylone arrives within twenty to forty minutes as a dual signal: rising energy paired with a growing warmth. The heart rate picks up, a flush of heat builds in the chest and face, and there is an emerging sense of empathogenic openness that colors the stimulant push with emotional richness. The transition from sober to affected is relatively smooth, without the abrupt switch that characterizes some cathinones.
As the effects develop, ephylone occupies a space between stimulant and empathogen. Social warmth increases meaningfully: conversations become more engaged and emotionally generous, barriers between people lower, and there is a genuine desire for closeness and connection. Touch sensitivity is enhanced, and music takes on added emotional and physical resonance. The stimulant component provides a moderate energy that keeps the body active and alert. The jaw clenches, pupils dilate, appetite vanishes, and body temperature rises. The overall character is sociable and warm, well-suited to settings where connection and movement coexist.
At the peak, roughly one to two hours in, the empathogenic quality is at its strongest. The emotional openness feels authentic and sometimes surprisingly deep, more than what the mild reputation of the compound might suggest. There is moderate euphoria, a warm and buzzing pleasure that combines the satisfaction of social connection with the physical reward of stimulation. The headspace is clear enough for coherent conversation but shaped by the emotional current. Physical effects are moderate and typical of the cathinone class.
The decline begins around three to four hours in and carries a moderate serotonergic weight. The warmth fades and is replaced by a growing tiredness and emotional quietness. The stimulant edge may persist somewhat beyond the empathogenic component, leaving a period of alert but emotionally flat wakefulness. The comedown is not severe but is noticeable: mild fatigue, subdued mood, and a general sense of neurochemical expenditure. Sleep may be slightly disrupted. The following day typically brings a mild flatness that resolves by evening. The total experience is pleasant and sociable, occupying a middle ground in the cathinone empathogen space without reaching the heights or depths of more potent compounds.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(14)
- Abnormal heartbeat— Abnormal heartbeat (arrhythmia) is any deviation from the heart's normal rhythm — including beats th...
- Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
- Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
- Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
- Increased blood pressure— Increased blood pressure (hypertension) is an elevation of arterial pressure above the normal 120/80...
- Increased bodily temperature— Increased bodily temperature (hyperthermia) is an elevation of core body temperature above the norma...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Serotonin syndrome— Serotonin syndrome is a potentially fatal medical emergency caused by excessive serotonergic activit...
- Stamina enhancement— Stamina enhancement is an increase in one's ability to sustain physical and mental exertion over ext...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
- Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
- Temperature regulation disruption— Impaired thermoregulation causing unpredictable fluctuations between feeling hot and cold, with risk...
Tactile(1)
- Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...
Cognitive & Perceptual Effects
Visual(2)
- Shadow people— The perception of dark, humanoid silhouettes lurking in peripheral vision or standing in direct line...
- Transformations— Objects and scenery undergo perceived visual metamorphosis, smoothly shapeshifting into other recogn...
Cognitive(20)
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
- Cognitive fatigue— Mental exhaustion and difficulty sustaining thought after intense cognitive experiences, common duri...
- Compulsive redosing— An overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maint...
- Delusion— A delusion is a fixed, false belief that is held with unshakeable certainty and is impervious to con...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Disinhibition— A marked reduction in social inhibitions, self-consciousness, and behavioral restraint that manifest...
- Ego inflation— Grandiose overconfidence and inflated self-importance, opposite of ego death, commonly produced by s...
- Empathy enhancement— A state of intensified compassion and emotional openness in which one feels deeply connected to othe...
- Focus enhancement— An enhanced ability to direct and sustain attention on a single task or stimulus with unusual clarit...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Irritability— Irritability is a sustained state of emotional reactivity in which the threshold for annoyance, frus...
- Motivation enhancement— A heightened sense of drive, ambition, and willingness to accomplish tasks, making productive effort...
- Motivation suppression— Motivation suppression is a state of diminished drive and willingness to engage in goal-directed beh...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Sensed presence— Sensed presence is the vivid and often unshakeable feeling that an unseen conscious being — whether ...
- Thought deceleration— The experience of thoughts occurring at a markedly reduced pace, as if the mind has been placed into...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Pharmacology
Mechanism of Action
Very little specific data exists on ephylone's human pharmacokinetics and pharmacodynamics. Based on its structural membership in the MDxx cathinone class and analogy with closely related compounds (pentylone, ethylone, methylone), ephylone is expected to act as a triple monoamine reuptake inhibitor and releasing agent — targeting the serotonin transporter (SERT), dopamine transporter (DAT), and norepinephrine transporter (NET).
The methylenedioxy ring system — the same structural feature present in MDMA — is believed to contribute to the serotonergic activity that produces the entactogenic qualities of MDxx cathinones. The N-ethyl modification (versus N-methyl in ethylone or N-methyl in methylone) alters the compound's transporter binding characteristics and metabolic profile.
MDxx Cathinone Pharmacological Context
Synthetic cathinones exert their stimulant and sympathomimetic effects by increasing synaptic concentrations of catecholamines through reuptake inhibition and/or active release. The balance of activity at SERT, DAT, and NET determines the qualitative character of the experience:
- High SERT relative to DAT activity: more entactogenic, MDMA-like (methylone, butylone)
- High DAT relative to SERT activity: more stimulant, less empathogenic (pentedrone, A-PVP)
- Ephylone is estimated to occupy a mixed position, similar to other MDxx cathinones
Beta-Ketone Modification
The beta-ketone (cathinone modification) present in ephylone, as in all synthetic cathinones, reduces the compound's lipophilicity compared to its non-cathinone counterpart, reducing blood-brain barrier penetration and typically resulting in shorter duration and somewhat lower CNS potency than the corresponding phenethylamine.
Detection Methods
Standard Drug Panel Inclusion
Ephylone (N-Ethylpentylone) is a substituted cathinone (synthetic cathinone) that is not included on standard 5-panel or 10-panel immunoassay drug screens. Some extended panels (particularly those marketed for "bath salts" detection) may include cross-reactive antibodies for the cathinone class, but coverage is inconsistent. The structural relationship to amphetamine means some cathinones trigger the amphetamine channel on immunoassays, but this is compound-specific and unreliable for Ephylone (N-Ethylpentylone).
Urine Detection
Ephylone (N-Ethylpentylone) and its metabolites can typically be detected in urine for 2 to 4 days following a single dose. Repeated or binge-pattern use may extend this window to 5 or more days. Primary metabolic pathways involve reduction of the beta-keto group, N-dealkylation, and hydroxylation. The resulting metabolites are excreted renally, often as glucuronide or sulfate conjugates.
Blood and Saliva Detection
Blood detection windows for Ephylone (N-Ethylpentylone) range from 12 to 48 hours depending on dose and individual metabolism. Plasma concentrations decline rapidly due to extensive distribution into tissues. Oral fluid testing can detect Ephylone (N-Ethylpentylone) for approximately 24 to 48 hours but is not commonly deployed for synthetic cathinones outside of specialized forensic settings.
Hair Follicle Detection
Hair analysis can detect synthetic cathinones including Ephylone (N-Ethylpentylone) for up to 90 days. Incorporation into the hair shaft follows standard pharmacokinetic principles for basic amines. However, most commercial hair testing panels do not specifically target Ephylone (N-Ethylpentylone), requiring custom LC-MS/MS methods with appropriate reference standards.
Confirmatory Testing
Definitive identification of Ephylone (N-Ethylpentylone) requires instrumental analysis. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the preferred method for synthetic cathinones due to their thermal lability, which can cause degradation during gas chromatography. GC-MS remains usable but may require derivatization for optimal sensitivity. Reference standards specific to Ephylone (N-Ethylpentylone) are necessary for quantitative confirmation.
Reagent Testing
Marquis reagent typically produces no reaction or a faint yellow-orange color with Ephylone (N-Ethylpentylone). Mecke reagent may show no significant color change. Mandelin reagent can produce a yellow to brown reaction. The lack of strong, characteristic color reactions with common reagents makes cathinone identification by reagent testing alone unreliable. A combination of Marquis, Mecke, Mandelin, and Simon's reagents can help rule out other substance classes but cannot positively confirm Ephylone (N-Ethylpentylone).
Interactions
| Substance | Status | Note |
|---|---|---|
| 25x-NBOH | Dangerous | — |
| 25x-NBOMe | Dangerous | — |
| Atropa belladonna | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Datura | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Diphenhydramine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Harmala alkaloid | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| Peganum harmala | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| MDMA | Unsafe | — |
| 1,3-Butanediol | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25E-NBOH | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-2 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-21 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Alcohol | Uncertain | — |
| Dissociatives | Uncertain | — |
History
Emergence
Ephylone first appeared in forensic drug databases and early warning systems in Europe in the mid-2010s as part of the continuing wave of MDxx cathinone NPS. It has been identified in drug seizures and toxicological analyses in multiple countries, primarily as a street drug sold under various names.
Classification Context
Ephylone's emergence followed the widespread scheduling of earlier MDxx cathinones including methylone, ethylone, and butylone, representing the continuing structural modification strategy by which novel cathinones evade regulation while maintaining pharmacological activity.
Regulatory Status
Ephylone has been controlled in numerous jurisdictions. It is explicitly scheduled in the UK, EU member states, Australia, and many other countries. In the US, it may be subject to federal analogue scheduling depending on structural analysis.
Forensic Significance
Ephylone has been identified in toxicological analyses associated with adverse events and fatalities attributed to MDxx cathinone use, contributing to public health surveillance data on this compound class.
Harm Reduction
Test Your Substance
MDxx cathinones cannot be reliably distinguished by appearance. Use reagent testing:
- Marquis: Orange to brown for cathinone class (contrast with MDMA which gives purple-black)
- Mecke: Blue-green for MDxx cathinones
- Test for fentanyl with fentanyl test strips
MDMA Harm Reduction Principles Apply
Harm reduction principles developed for MDMA provide the most relevant baseline for ephylone:
- Space use by at least 4–8 weeks minimum; longer spacing is better
- Avoid hot, physically active environments without temperature management
- Maintain hydration but avoid over-drinking (hyponatremia risk)
Avoid MAOIs Absolutely
MAOIs with any serotonergic cathinone is an absolutely contraindicated combination that can be life-threatening.
Temperature Management
In dance or active environments, take breaks, cool down, and monitor temperature. Hyperthermia is a serious risk.
Do Not Combine Entactogens
Stacking ephylone with MDMA or other MDxx compounds is not safer than using either alone — it compounds serotonin syndrome risk without equivalent increase in harm reduction-relevant benefit.
Toxicity & Safety
Entactogen and Stimulant Risk Profile
Ephylone combines the risk profiles of both classes:
Stimulant risks:
- Cardiovascular stimulation (elevated heart rate, blood pressure)
- Hyperthermia risk (particularly in active environments)
- Sleep disruption
- Anxiety and paranoia at higher doses
Entactogen risks:
- Serotonin syndrome risk in combination with other serotonergic agents
- Post-use serotonergic depletion contributing to comedown
- Potential for serotonin-mediated neurotoxicity with repeated heavy use
Serotonin Syndrome Risk
The serotonergic component of ephylone means that combining with MAOIs poses serious risk of serotonin syndrome — a potentially fatal condition characterized by hyperthermia, neuromuscular abnormalities, and autonomic instability. This combination is absolutely contraindicated.
Uncertain Toxicology
Ephylone is inadequately characterized in formal toxicological literature. This uncertainty is itself a harm: unknown long-term effects, unclear dose-response relationships, and uncharacterized drug interaction profiles.
Compulsive Redosing
The short duration of MDxx cathinones creates pressure to redose. Euphylone's entactogenic component does not mitigate this risk, and may add a social/emotional dimension to the redosing motivation.
Addiction Potential
moderately addictive with a high potential for abuse
Overdose Information
overdose deaths indicate that ephylone is extremely toxic at very high dosages. The DEA claimed approximately 151 ephylone-related deaths occurred in the U.S. between 2014 and 2018. Higher dosages of ephylone have been linked to serotonin syndrome, rhabdomyolysis, kidney injury, acidemia and other life-threatening symptoms.
Germany: Ephylone is controlled under Anlage II BtMG (Narcotics Act, Schedule II) as of December 21, 2019. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.
Switzerland: Ephylone can be considered a controlled substance as a defined derivative of Cathinone under Verzeichnis E point 1. It is legal when used for scientific or industrial use.
United States: On July 13, 2018, the DEA issued a temporary scheduling order to place ephylone in schedule I of the Controlled Substances Act (CSA). This makes the production, sale, and possession of ephylone illegal.
Responsible use
Entactogens
Stimulants
Cathinones
Ephylone (Wikipedia)
Ephylone (Isomer Design)
Prosser, J. M., & Nelson, L. S. (2012). The toxicology of bath salts: a review of synthetic cathinones. Journal of Medical Toxicology, 8(1), 33-42. https://doi.org/0.1007/s13181-011-0193-z.
Wood, M. R., Bernal, I., & Lalancette, R. A. (2017). The hydrochloride hydrates of pentylone and dibutylone and the hydrochloride salt of ephylone: the structures of three novel designer cathinones. Structural Chemistry, 28(5), 1369-1376. http://dx.doi.org/10.1007/s11224-017-0951-x
Krotulski, A. J., Papsun, D. M., De Martinis, B. S., Mohr, A. L., & Logan, B. K. (2018). N-Ethyl Pentylone (Ephylone) Intoxications: Quantitative Confirmation and Metabolite Identification in Authentic Human Biological Specimens. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bky025
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Tolerance
| Full | develops with prolonged and repeated use |
| Half | Unknown |
| Zero | Unknown |
Cross-tolerances
Legal Status
Ephylone is currently unscheduled in most parts of the world.
Brazil: On September 7, 2018, all Cathinone analogues are controlled substances considered illegal to possess, use and distribute. This was made possible due to a blanket ban law appended to Portaria SVS/MS nº 344.
Germany: Ephylone is controlled under Anlage II BtMG (Narcotics Act, Schedule II) as of December 21, 2019. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.
Switzerland: Ephylone can be considered a controlled substance as a defined derivative of Cathinone under Verzeichnis E point 1. It is legal when used for scientific or industrial use.
United States: On July 13, 2018, the DEA issued a temporary scheduling order to place ephylone in schedule I of the Controlled Substances Act (CSA). This makes the production, sale, and possession of ephylone illegal.
Responsible use
Entactogens
Stimulants
Cathinones
Ephylone (Wikipedia)
Ephylone (Isomer Design)
Prosser, J. M., & Nelson, L. S. (2012). The toxicology of bath salts: a review of synthetic cathinones. Journal of Medical Toxicology, 8(1), 33-42. https://doi.org/0.1007/s13181-011-0193-z.
Wood, M. R., Bernal, I., & Lalancette, R. A. (2017). The hydrochloride hydrates of pentylone and dibutylone and the hydrochloride salt of ephylone: the structures of three novel designer cathinones. Structural Chemistry, 28(5), 1369-1376. http://dx.doi.org/10.1007/s11224-017-0951-x
Krotulski, A. J., Papsun, D. M., De Martinis, B. S., Mohr, A. L., & Logan, B. K. (2018). N-Ethyl Pentylone (Ephylone) Intoxications: Quantitative Confirmation and Metabolite Identification in Authentic Human Biological Specimens. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bky025
Experience Reports (2)
Tips (5)
Supplement magnesium glycinate when using Ephylone to reduce jaw clenching, muscle tension, and bruxism. Also maintain electrolytes, B vitamins, and vitamin C which are depleted faster under stimulant use.
Stay hydrated while using Ephylone. Stimulants increase heart rate and body temperature while suppressing thirst signals. Sip water regularly, roughly 250-500ml per hour, more if dancing or in hot environments.
Weigh your dose of Ephylone with a milligram scale. Street stimulants vary wildly in purity and potency. What looks like a normal amount could be significantly stronger than expected, especially with a new batch.
Have a landing plan for the Ephylone comedown. Prepare food, melatonin or magnesium, and a comfortable environment in advance. Avoid using depressants to manage the comedown as this creates polydrug dependency patterns.
Avoid binge patterns with Ephylone. Sleep deprivation combined with stimulant use dramatically increases psychosis risk after 48+ hours awake. If you find yourself redosing to avoid the comedown, that is a major warning sign.
See Also
References (5)
- Amphetamine: new content for an old topic — Heal et al. Neuropsychopharmacology Reviews (2013)paper
- MDMA-assisted therapy for PTSD — Mithoefer et al. Psychopharmacology (2019)paper
- PubChem: Ephylone
PubChem compound page for Ephylone (CID: 57359308)
pubchem - Ephylone - TripSit Factsheet
TripSit factsheet for Ephylone
tripsit - Ephylone - Wikipedia
Wikipedia article on Ephylone
wikipedia